Conjugate | Product Code | Application |
---|---|---|
HRP | CSB-PA24359B0Rb | ELISA |
FITC | CSB-PA24359C0Rb | Immunofluorescence, Flow Cytometry |
Biotin | CSB-PA24359D0Rb | ELISA, Avidin-Biotin Complex assays |
The antibody’s versatility is enhanced by its compatibility with multiple detection methods. For example, the HRP conjugate enables sensitive chemiluminescent detection in ELISA, while the FITC conjugate supports fluorescence-based imaging .
The skib protein is a nuclear oncoprotein implicated in transcriptional regulation and cellular transformation. Key features include:
Functional Domains: Structural motifs critical for DNA binding and protein interactions.
Biological Role: Modulates gene expression pathways linked to oncogenesis and embryonic development.
Localization: Primarily nuclear, consistent with its role in transcriptional regulation .
skib Antibody has been employed in:
Western Blot: Detects skib protein in zebrafish tissue lysates at dilutions of 1:500–1:5000 .
ELISA: Quantifies skib expression levels in experimental models.
Immunofluorescence: Visualizes subcellular localization in fixed cells or tissues .
Specificity: Validated against recombinant zebrafish skib protein (289-438AA).
Cross-Reactivity: No observed reactivity with non-target species or proteins .
Batch Consistency: Rigorous quality checks ensure reproducibility across lots .
Feature | skib Antibody | Ski Antibody (G8) |
---|---|---|
Target Species | Zebrafish | Mouse, Rat, Human |
Applications | WB, ELISA | WB, IP, IF |
Conjugates | HRP, FITC, Biotin | Agarose, HRP, PE, FITC, Alexa Fluor® |
Biological Context | Oncogenesis | TGFβ signaling, Smad protein regulation |
Further studies could explore:
Skib is a protein found in zebrafish with the Uniprot ID Q9YI02. This protein plays significant roles in zebrafish development and biological processes. Understanding skib function provides insights into developmental biology, gene regulation, and potentially conserved mechanisms across species. The skib antibody serves as a crucial tool for detecting and studying this protein in various experimental contexts .
Currently, researchers can access rabbit polyclonal antibodies to skib, such as the CSB-PA24359A0Rb. These antibodies are generated by immunizing rabbits with specific skib protein epitopes, resulting in a heterogeneous mixture of antibodies that recognize multiple epitopes on the skib protein . Unlike monoclonal antibodies which recognize a single epitope, polyclonal antibodies like the skib antibody provide broader detection capability but may have batch-to-batch variation that researchers should account for in experimental design .
The skib antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications in zebrafish samples . These techniques allow researchers to detect and quantify skib protein expression in various tissues and developmental stages. While not explicitly validated for other applications like immunohistochemistry or immunofluorescence, researchers might optimize conditions to expand its utility, following general principles of antibody application optimization outlined in antibody design literature .
Validating antibody specificity is crucial for reliable research outcomes. For skib antibody, consider implementing these validation approaches:
Positive and negative controls: Include wild-type zebrafish samples (positive control) and skib-knockout or knockdown samples (negative control).
Pre-absorption test: Pre-incubate the antibody with purified skib protein before immunostaining or Western blotting to confirm specificity.
Multiple antibody approach: When possible, use antibodies from different sources or that recognize different epitopes of skib.
Molecular weight verification: Confirm that the detected band matches the expected molecular weight of skib protein.
Cross-reactivity assessment: Test the antibody against closely related proteins to ensure specificity .
Antibody validation approaches should be documented in publications to enhance reproducibility of research findings.
Optimizing Western blot conditions for skib antibody requires systematic evaluation of several parameters:
Parameter | Recommended Conditions | Optimization Notes |
---|---|---|
Blocking agent | 5% non-fat milk or BSA in TBST | Test both to determine optimal signal-to-noise ratio |
Primary antibody dilution | 1:1000 to 1:2000 | Titrate to determine optimal concentration |
Incubation time | Overnight at 4°C | Compare with shorter incubations at room temperature |
Washing buffer | TBST (0.1% Tween-20) | Ensure thorough washing to reduce background |
Secondary antibody | Anti-rabbit IgG-HRP | Dilute according to manufacturer's recommendation |
Detection method | Enhanced chemiluminescence | Compare standard vs. high-sensitivity substrates |
Researchers should note that optimization may be necessary for each new lot of antibody, as polyclonal antibodies can exhibit batch-to-batch variation .
Antibody affinity significantly impacts experimental results, particularly in detecting low-abundance proteins like skib in complex biological samples. Higher affinity antibodies can:
Improve sensitivity for detecting low levels of skib protein
Allow for more stringent washing conditions, reducing non-specific background
Provide more consistent results across experiments
Potentially work at higher dilutions, conserving reagents
The affinity of polyclonal antibodies like the skib antibody can be influenced by immunization strategies and purification methods. Researchers investigating rare or low-abundance skib expression should consider affinity as a critical factor in experimental design and interpretation .
For optimal ELISA performance with skib antibody, follow this methodological approach:
Plate coating: Coat 96-well plates with antigen (cell/tissue lysate containing skib) at 1-10 μg/ml in carbonate buffer (pH 9.6) overnight at 4°C.
Blocking: Block with 3% BSA or 5% non-fat milk in PBS for 1-2 hours at room temperature.
Primary antibody: Dilute skib antibody (CSB-PA24359A0Rb) at 1:500 to 1:2000 in blocking buffer. Incubate for 2 hours at room temperature or overnight at 4°C.
Washing: Wash 4-5 times with PBS-T (0.05% Tween-20).
Secondary antibody: Apply HRP-conjugated anti-rabbit IgG at recommended dilution. Incubate for 1-2 hours at room temperature.
Detection: Develop with TMB substrate and measure absorbance at 450nm.
Controls: Include positive control (known skib-expressing sample), negative control (sample without skib), and antibody controls (no primary antibody) .
This protocol may require optimization for specific sample types and experimental questions.
Non-specific binding can compromise research data quality. When working with skib antibody, consider these troubleshooting approaches:
Increase blocking stringency: Extend blocking time or use alternative blocking agents like fish gelatin or synthetic blockers.
Optimize antibody concentration: Perform a dilution series to identify the concentration that maximizes specific signal while minimizing background.
Modify washing conditions: Increase wash duration, volume, or detergent concentration to remove weakly bound antibodies.
Pre-absorb the antibody: Incubate the diluted antibody with zebrafish tissue lacking skib expression to remove antibodies that bind non-specifically.
Adjust buffer composition: Add components like 0.1-0.5% NP-40/Triton X-100 to reduce hydrophobic interactions, or increase salt concentration to reduce ionic interactions .
Systematic documentation of optimization steps helps establish reliable protocols for future experiments.
Co-localization studies require careful planning to generate reliable spatial information about skib and other proteins:
Antibody compatibility: Ensure the skib antibody (rabbit polyclonal) is compatible with other antibodies used (ideally from different host species).
Sequential immunostaining: For antibodies from the same host, consider sequential immunostaining with complete blocking between rounds.
Controls for spectral overlap: Include single-antibody controls to assess and correct for fluorophore spectral bleed-through.
Resolution considerations: Match imaging resolution to the biological question—super-resolution techniques may be necessary for detailed subcellular co-localization.
Quantitative analysis: Apply appropriate statistical methods and co-localization coefficients (Pearson's, Mander's) for objective evaluation.
Biological validation: Confirm co-localization findings with complementary approaches such as proximity ligation assay or co-immunoprecipitation .
Sample preparation significantly impacts antibody binding efficiency. For skib antibody applications, consider these methodological approaches:
Fixation: For most applications, 4% paraformaldehyde (PFA) for 24-48 hours (depending on sample size) preserves most epitopes while maintaining tissue architecture.
Temperature considerations: Perform fixation at 4°C to minimize protein degradation and epitope modification.
Buffer selection: Use phosphate-buffered fixatives at physiological pH (7.2-7.4) to preserve native protein conformation.
Antigen retrieval: For formalin-fixed tissues, heat-induced epitope retrieval (citrate buffer pH 6.0) may improve antibody access to skib epitopes.
Permeabilization: For whole-mount preparations, carefully optimize detergent concentration and exposure time to balance antibody access with epitope preservation .
These considerations help ensure that the target epitopes remain accessible to the skib antibody while maintaining tissue morphology.
Proper storage is essential for preserving antibody functionality over time:
Long-term storage: Store at -20°C or preferably -80°C in small aliquots to avoid repeated freeze-thaw cycles.
Working dilutions: Store diluted antibody at 4°C for no more than 1-2 weeks.
Avoid freeze-thaw cycles: Each freeze-thaw cycle can reduce antibody activity by 10-20%; make small aliquots upon receipt.
Buffer considerations: The skib antibody is supplied in 50% glycerol with 0.01M PBS (pH 7.4) and 0.03% Proclin 300 preservative, which helps maintain stability.
Temperature monitoring: Ensure freezer temperatures remain stable; temperature fluctuations can accelerate antibody degradation .
Following these storage guidelines will help maintain the sensitivity and specificity of the skib antibody throughout your research project.
Quantitative analysis of Western blots requires a systematic approach:
Image acquisition: Use a digital imaging system with a linear dynamic range appropriate for your signal intensity.
Loading controls: Always include appropriate loading controls (β-actin, GAPDH) and normalize skib signal to these controls.
Standard curves: For absolute quantification, include a standard curve using recombinant skib protein.
Software analysis: Use dedicated analysis software (ImageJ, Image Lab) to measure band intensity while subtracting background.
Replicate analysis: Perform at least three biological replicates and appropriate technical replicates.
Statistical analysis: Apply appropriate statistical tests based on your experimental design and data distribution.
Analysis Step | Method | Key Considerations |
---|---|---|
Background subtraction | Rolling ball algorithm | Adjust radius based on band width |
Lane normalization | Housekeeping protein | Ensure linear range for both target and reference |
Comparison between blots | Internal control sample | Include identical sample on all blots for inter-blot normalization |
Statistical analysis | ANOVA or t-test | Test for normality before choosing parametric tests |
This systematic approach ensures reliable quantitative comparisons of skib protein expression across different experimental conditions .
Researchers should be aware of these potential pitfalls in data interpretation:
Cross-reactivity: The polyclonal nature of skib antibody means it may recognize proteins with similar epitopes, leading to misidentification.
Splice variants: Different isoforms of skib may be present in different tissues or developmental stages, affecting band patterns on Western blots.
Post-translational modifications: Phosphorylation, glycosylation, or other modifications can alter apparent molecular weight or epitope accessibility.
Artifacts from sample preparation: Protein degradation or aggregation can create misleading bands or signals.
Non-specific binding: Particularly in immunohistochemistry, background staining can be misinterpreted as specific signal.
Antibody lot variation: Different lots of polyclonal antibodies may have different specificities and optimal working conditions.
To address these issues, researchers should implement appropriate controls, validate findings with complementary approaches, and document antibody information (including lot number) in publications .
Adapting skib antibody for high-throughput applications requires optimization and standardization:
Automated platforms: Adapt ELISA protocols for robotic liquid handling systems with optimized antibody concentrations and incubation times.
Multiplex analysis: Consider using skib antibody in multiplex bead-based assays to simultaneously detect multiple proteins.
Miniaturization: Reduce reaction volumes and adapt to microplate formats (384 or 1536-well) for resource conservation.
Quality control: Implement rigorous quality control measures including Z-factor calculation to ensure assay robustness.
Data management: Develop automated data analysis pipelines to process large datasets efficiently.
These adaptations can facilitate large-scale studies of skib protein expression across multiple conditions or genetic backgrounds .
Recent advances in antibody engineering may enhance skib antibody applications:
Recombinant antibody development: Single-chain variable fragments (scFvs) or antigen-binding fragments (Fabs) could provide more consistent alternatives to polyclonal antibodies.
Affinity maturation: Techniques like directed evolution can generate higher-affinity variants for detecting low-abundance skib protein.
Site-specific conjugation: New methods for controlled conjugation can improve performance in applications requiring labeled antibodies.
Bispecific antibodies: Engineered antibodies recognizing both skib and another protein of interest could facilitate co-localization or pull-down studies.
Alternative binding scaffolds: Non-antibody protein scaffolds with tailored binding properties might offer advantages for specific applications.
These emerging technologies may address current limitations of polyclonal skib antibodies, particularly regarding specificity, reproducibility, and application versatility .